USPTO serial 79293495
ABOCA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ABOCA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Pomades, creams, non-medicated general purpose ointments, lotions, gels and other preparations in the nature of cosmetic preparations for skin care, all for cosmetic purposes, all containing plants, plant extracts, molecular complexes from plants; pomades, creams, non-medicated general purpose ointments, lotions, gels and other preparations in the nature of cosmetic preparations for skin care, all for cosmetic purposes; deodorants for personal use, being perfumery; hand cleaners, being hand cleaning preparations; phytocosmetic preparations; bases for flower perfumes, namely, essential oils; extracts of flowers being perfumes; perfumery, fragrances and incense; room fragrancing preparations; scented room sprays | ACTIVE | — |
| 005 | Medical preparations being medicinal preparations in accordance with the EU Regulation 2017/745 all containing plants, plant extracts, molecular complexes from plants, all in the form of sprays, ointments, creams, pomades, tablets, capsules, gel capsules, lozenges, granules, pills, suppositories, tisanes, infusions, syrups, fluids, liquids, lotions, gels, powders and in lyophilized form, all for improving and maintaining digestion and intestinal health, for the treatment of constipation and intestinal transit disorders, for restoring the balance of the intestinal flora and for regulating intestinal function, for the treament of irritable bowel syndrome, diarrhea, haemorrhoids, gastroesophageal reflux and of epigastric pain, for slimming purposes, for weight control, for managing glycaemic peaks, for the treatment of the cough and for the care of the upper respiratory tract, for the prevention and treatment of mucous irritations, for reducing cholesterol and triglycerides, for relaxing, for sleeping, for improving memory and microcirculation, for throat and oral cavity care, or the treatment of irritative and inflammatory states of the oropharyngeal cavity, for heartburn and stomach pain, for strengthening the immune system; medical preparations being medicinal preparations in accordance with the EU Regulation 2017/745 for treating and preventing cardiovascular diseases, obesity and excess weight, gastrointestinal disorders and diseases, osteoporosis, for diet, for treating sleep disorders, for respiratory' airway health, oropharyngeal tract health and for improving memory' and mood balance; pharmaceutical preparations for treating and preventing cardiovascular diseases, obesity and excess weight, gastrointestinal disorders and diseases, osteoporosis, for diet, respiratory airway health, for oropharyngeal tract health and for improving memory and mood balance; medicinal herbs; herbal preparations for medical purposes; phytotherapy preparations for medical purposes; mineral food supplements; dietetic food supplements; vitamin supplements; nutritional supplements; herb based food supplements; food supplements for balancing the intestinal flora; probiotic preparations for medical use; mixed vitamin preparations; herbal teas for medical purposes; herbal infusions for medical purposes for treating gastrointestinal diseases, intestinal disorders, sore throat, water retention, flu, bad digestion, cholesterol; medicinal tea; dietetic foods and beverages adapted for medical purposes; cachets being capsules sold empty for pharmaceutical purposes; ginseng capsules for medical purposes; food supplement tablets for medical purposes; lozenges for medical purposes; gel capsules sold empty for medical purposes; syrups for medical purposes for treating cold, cough, flu, sore throat and for the care of the upper respiratory tract; medicinal oils; balms for medical purposes; pomades for medical purposes; massage gels for medical purposes; medicated skin care creams for medical purposes; medicated skin care lotions for medical use; medicinal sprays, namely, antibacterial sprays; medicated emulsions for skin care, in the form of sprays, namely, medicated lotions for treating dermatological conditions; medicated soap; disinfectant soap; antibacterial soap; laxatives; anti-oxidants for use as dietary supplements; depuratives for the body; medicated hair tonics, being medicines; antibacterial alcohol skin sanitizer gel; hand-sanitizing preparations; antibacterial hand lotions; medicated hand wash; dietary supplements for human consumption | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ABOCA S.P.A. SOCIETA' AGRICOLA
- Other trademarks owned by ABOCA S.P.A. SOCIETA' AGRICOLA
- Other trademarks owned by ABOCA S.P.A. SOCIETA' AGRICOLA
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named ABOCA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 2, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 1, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 29, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 9, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 21, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 18, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 18, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 16, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 10, 2020 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |